{
    "nct_id": "NCT04742361",
    "official_title": "Phase III Study of [18F]PSMA-1007 Positron Emission Tomography for the Detection of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer",
    "inclusion_criteria": "* Male with original diagnosis of adenocarcinoma of the prostate with prior definitive therapy\n* Suspicion of recurrence or persistence\n\n  * after radiotherapy or cryotherapy: 3 consecutive PSA rises and/or PSA rise by 2.0 ng/mL or more above nadir (ASTRO-Phoenix)\n  * after prostatectomy, PSA > 0.2 ng/mL on 2 or more determinations (recurrence), or failure of PSA to fall to undetectable levels post-prostatectomy (persistence) (American Urological Association)\n* For patients who previously had radical prostatectomy, salvage radiotherapy is one likely treatment plan; for patients who initially underwent radiotherapy (including brachytherapy), confirmation of low volume disease is needed to define (local) treatment.\n* Life expectancy of 6 months or more as judged by the investigator\n* Willing and able to undergo all study procedures\n* Informed consent in writing\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Age: less than18 years\n* Contraindications to any of the ingredients of [18F]PSMA-1007\n* Close affiliation with the investigational site\n* At the time of enrolment into this study, participating in another therapeutic clinical trial or has completed study participation in another therapeutic clinical trial within 5 days of enrolment into this trial\n* Having been previously enrolled in this clinical trial\n* Mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial\n* Being clinically unstable or requiring emergency treatment\n* Patients who are unwilling to consider a biopsy if clinically recommended\n* Patients who are unable to undergo a PET/CT scan\n* Patients for whom systemic therapy is the most likely course regardless of PET findings.",
    "miscellaneous_criteria": ""
}